350 related articles for article (PubMed ID: 8968360)
1. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide.
Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360
[TBL] [Abstract][Full Text] [Related]
2. Carrier-mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats. Comparison between in vivo and in vitro.
Yamada T; Niinuma K; Lemaire M; Terasaki T; Sugiyama Y
Drug Metab Dispos; 1997 May; 25(5):536-43. PubMed ID: 9152591
[TBL] [Abstract][Full Text] [Related]
3. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR).
Ishizuka H; Konno K; Naganuma H; Sasahara K; Kawahara Y; Niinuma K; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1304-11. PubMed ID: 9067317
[TBL] [Abstract][Full Text] [Related]
4. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter.
Yamazaki M; Akiyama S; Ni'inuma K; Nishigaki R; Sugiyama Y
Drug Metab Dispos; 1997 Oct; 25(10):1123-9. PubMed ID: 9321514
[TBL] [Abstract][Full Text] [Related]
5. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.
Yamazaki M; Kobayashi K; Sugiyama Y
Biopharm Drug Dispos; 1996 Oct; 17(7):607-21. PubMed ID: 8894118
[TBL] [Abstract][Full Text] [Related]
6. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats.
Sasabe H; Tsuji A; Sugiyama Y
J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864
[TBL] [Abstract][Full Text] [Related]
7. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinaemic rats.
Yamazaki M; Kobayashi K; Sugiyama Y
Biopharm Drug Dispos; 1996 Nov; 17(8):645-59. PubMed ID: 8950045
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective hepatobiliary transport of the quinolone antibiotic grepafloxacin and its glucuronide in the rat.
Sasabe H; Kato Y; Tsuji A; Sugiyama Y
J Pharmacol Exp Ther; 1998 Feb; 284(2):661-8. PubMed ID: 9454812
[TBL] [Abstract][Full Text] [Related]
9. Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in rats.
Chu XY; Kato Y; Niinuma K; Sudo KI; Hakusui H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Apr; 281(1):304-14. PubMed ID: 9103511
[TBL] [Abstract][Full Text] [Related]
10. Species differences in the transport activity for organic anions across the bile canalicular membrane.
Ishizuka H; Konno K; Shiina T; Naganuma H; Nishimura K; Ito K; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1999 Sep; 290(3):1324-30. PubMed ID: 10454510
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats.
Sathirakul K; Suzuki H; Yasuda K; Hanano M; Tagaya O; Horie T; Sugiyama Y
J Pharmacol Exp Ther; 1993 Jun; 265(3):1301-12. PubMed ID: 8510010
[TBL] [Abstract][Full Text] [Related]
12. Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan.
Nishino A; Kato Y; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2000 Oct; 28(10):1146-8. PubMed ID: 10997931
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent.
Murata M; Tamai I; Sai Y; Nagata O; Kato H; Sugiyama Y; Tsuji A
Drug Metab Dispos; 1998 Nov; 26(11):1113-9. PubMed ID: 9806954
[TBL] [Abstract][Full Text] [Related]
14. Alterations in glutathione homeostasis in mutant Eisai hyperbilirubinemic rats.
Lu SC; Cai J; Kuhlenkamp J; Sun WM; Takikawa H; Takenaka O; Horie T; Yi J; Kaplowitz N
Hepatology; 1996 Jul; 24(1):253-8. PubMed ID: 8707271
[TBL] [Abstract][Full Text] [Related]
15. Nonlinear disposition kinetics of a novel antifolate, MX-68, in rats.
Han YH; Kato Y; Sugiyama Y
J Pharmacol Exp Ther; 1999 Oct; 291(1):204-12. PubMed ID: 10490906
[TBL] [Abstract][Full Text] [Related]
16. Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
Han YH; Kato Y; Watanabe Y; Terao K; Asoh Y; Sugiyama Y
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):394-400. PubMed ID: 11259322
[TBL] [Abstract][Full Text] [Related]
17. Impaired biliary excretion and whole body elimination of methylmercury in rats with congenital defect in biliary glutathione excretion.
Ballatori N; Gatmaitan Z; Truong AT
Hepatology; 1995 Nov; 22(5):1469-73. PubMed ID: 7590665
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of hepatobiliary transport for conjugated metabolites in the perfused liver of mutant rats (EHBR) with hereditary conjugated hyperbilirubinemia.
Takenaka O; Horie T; Kobayashi K; Suzuki H; Sugiyama Y
Pharm Res; 1995 Nov; 12(11):1746-55. PubMed ID: 8592681
[TBL] [Abstract][Full Text] [Related]
19. Different biliary excretion systems for glucuronide and sulfate of a model compound; study using Eisai hyperbilirubinemic rats.
Takenaka O; Horie T; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1995 Sep; 274(3):1362-9. PubMed ID: 7562509
[TBL] [Abstract][Full Text] [Related]
20. Hepatic uptake of bromosulfophthalein-glutathione in perfused Eisai hyperbilirubinemic mutant rat liver: a multiple-indicator dilution study.
Geng W; Schwab AJ; Horie T; Goresky CA; Pang KS
J Pharmacol Exp Ther; 1998 Feb; 284(2):480-92. PubMed ID: 9454788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
